ARTICLE | Company News
iCo scientific advisory board update
December 5, 2005 8:00 AM UTC
iCo Therapeutics Inc., Vancouver, B.C. Business: Neurology Appointed: Richard Glickman, chairman and CEO of Aspreva Pharmaceuticals Corp.; George Lasezkay, a principal at Turning Point Consultants LLC...